logo BDSP

Base documentaire

Fermeture du portail BDSP le 1er juillet 2019. En savoir plus...

  1. Hormone replacement treatment and breast cancer risk : a cooperative Italian study.

    Article - En anglais

    The relationship between hormone replacement treatment (HRT) and breast cancer risk was analysed using data from a case-control study conducted between June 1991 and February 1994 in six Italian centres on 2569 patients aged below 75 with histologically confirmed breast cancer and 2588 controls admitted to hospital for a wide spectrum of acute, non-neoplastic, non hormone-related diseases.

    There was no clear pattern of risk with reference to time since starting use, but the OR was significantly elevated for women who had stopped HRT within the last 10 years.

    No association was observed in those who had stopped HRT more than 10 years ago.

    The increased OR for women who had stopped HRT within the last 10 years was consistent across strata of identified covariates, and was significantly related to duration of use.

    This study confirms the absence of a strong association between HRT and breast cancer risk, although the risk estimate was above unity for women who had used HRT for 5 years or longer.

    However, the risk was significantly elevated in the short to medium term after use, particularly for long-term use.

    This short-term increased risk is consistent with an effect of HRT on one of the later stages of the process of breast carcinogenesis.

    The flattening of risk with increasing time since stopping, and hence the absence of a long-term cumulative excess in breast cancer risk after stopping HRT exposure, has relevant implications on individual risk assessment and public health.

    Mots-clés Pascal : Tumeur maligne, Glande mammaire, Epidémiologie, Facteur risque, Traitement substitutif, Hormone stéroïde sexuelle, Oestrogène, Progestérone, Progestatif, Toxicité, Italie, Europe, Homme, Glande mammaire pathologie, Etude cas témoin

    Mots-clés Pascal anglais : Malignant tumor, Mammary gland, Epidemiology, Risk factor, Replacement therapy, Sex steroid hormone, Estrogen, Progesterone, Progestagen, Toxicity, Italy, Europe, Human, Mammary gland diseases, Case control study

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 95-0428128

    Code Inist : 002B02U10. Création : 01/03/1996.

Fermeture du portail BDSP le 1er juillet 2019

Nous avons le regret de vous informer de la fermeture du portail BDSP le 1er juillet 2019. Du 1er janvier au 30 juin 2019, le site et ses services resteront accessibles mais ne seront plus alimentés, ni mis à jour. En savoir plus...